ADRENALIN DIN 02562200
Health Canada record
| Active ingredient(s) | EPINEPHRINE (EPINEPHRINE HYDROCHLORIDE) 1 MG |
|---|---|
| Dosage form | Solution |
| Route | Intracardiac; Intravenous; Ophthalmic; Intramuscular; Intraspinal; Subcutaneous |
| Schedule | ETHICAL |
| Class | Human |
| ATC | C01CA24 EPINEPHRINE |
| Original market date | |
| Current status date | 16-Oct-2025 |
| Source | Health Canada DPD |
Establishment licence of the holder
Searchlight Pharma Inc — licence 102247, currently licensed, last inspection rating C (2024-10-10).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing EPINEPHRINE (EPINEPHRINE HYDROCHLORIDE)
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 00155357 | ADRENALIN | SEARCHLIGHT PHARMA INC | Solution | EPINEPHRINE (EPINEPHRINE HYDROCHLORIDE) 1 MG | Marketed |
| 00155365 | ADRENALIN TOPICAL SOLUTION | SEARCHLIGHT PHARMA INC | Solution | EPINEPHRINE (EPINEPHRINE HYDROCHLORIDE) 1 MG | Marketed |